HuGE Literature Finder
Records
1
-
12
| Germline cancer gene expression quantitative trait loci are associated with local and global tumor mutations. Cancer research 2023 2 . Liu Yuxi, Gusev Alexander, Kraft Pet |
| Clinical Benefit With PARP Inhibitor for Pathogenic Germline FANCA-Mutated Relapsed Epithelial Ovarian Cancer: A Case Report. Frontiers in oncology 2022 3 12 778545. Qian Bing, Leng Wenshu, Yan Zhengqing, Lu Jin, Chen Shiqing, Yi Huan, Jiang Z |
| Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing. Cancers 2021 10 13 (20): . Wessman Sandra, Fuentes Beatriz Bohorquez, Törngren Therese, Kvist Anders, Kokaraki Georgia, Menkens Hanna, Hjerpe Elisabet, Hugo Ythalo, Petta Tirzah Braz, Borg Åke, Carlson Joseph |
| Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer. Aging 2020 Feb 12 . Chen Bo, Zhang Guochun, Li Xuerui, Ren Chongyang, Wang Yulei, Li Kai, Mok Hsiaopei, Cao Li, Wen Lingzhu, Jia Minghan, Li Cheukfai, Guo Liping, Wei Guangnan, Lin Jiali, Li Yingzi, Zhang Yuchen, Han-Zhang Han, Liu Jing, Lizaso Analyn, Liao Ni |
| Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients. Cancers 2020 4 12 (4): . Del Valle Jesús, Rofes Paula, Moreno-Cabrera José Marcos, López-Dóriga Adriana, Belhadj Sami, Vargas-Parra Gardenia, Teulé Àlex, Cuesta Raquel, Muñoz Xavier, Campos Olga, Salinas Mónica, de Cid Rafael, Brunet Joan, González Sara, Capellá Gabriel, Pineda Marta, Feliubadaló Lídia, Lázaro Con |
| Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms. Artificial cells, nanomedicine, and biotechnology 2019 Dec 47 (1): 1101-1112. Wang Le, Wang Hao, Wang Ting, Liu Jinhui, Chen Wei, Wang Yamin, Chen Chao, Zhu Hongli, Dai Pengg |
| Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2019 8 32 (Supplementum2): 6-13. Foretová Lenka, Navrátilová Marie, Svoboda Marek, Vaší?ková Petra, S?ahlová Eva Hrabincová, Házová Jana, Kleiblová Petra, Kleibl Zden?k, Machá?ková Eva, Palácová Markéta, Petráková Katarí |
| A rare FANCA gene variation as a breast cancer susceptibility allele in an Iranian population. Molecular medicine reports 2017 Apr . Abbasi Sakineh, Rasouli Mi |
| Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles. Human mutation 2013 Dec 34 (12): 1615-8. Osorio Ana, Bogliolo Massimo, Fernández Victoria, Barroso Alicia, de la Hoya Miguel, Caldés Trinidad, Lasa Adriana, Ramón y Cajal Teresa, Santamariña Marta, Vega Ana, Quiles Francisco, Lázaro Conxi, Díez Orland, Fernández Daniel, González-Sarmiento Rogelio, Durán Mercedes, Piqueras José Fernández, Marín Maria, Pujol Roser, Surrallés Jordi, Benítez Javi |
| Promoter CpG island methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 8 19 (20): 5788-5797. Dai Wei, Zeller Constanze, Masrour Nahal, Siddiqui Nadeem, Paul James, Brown Robe |
| The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features. Breast cancer research and treatment 2009 Jun . Barroso E, Pita G, Arias JI, Menendez P, Zamora P, Blanco M, Benitez J, Ribas G |
| A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer. BMC cancer 2005 5 (1): 43. Thompson Ella, Dragovic Rebecca L, Stephenson Sally-Anne, Eccles Diana M, Campbell Ian G, Dobrovic Alexand |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: